LB-100 for Injection
L12-20661
Phase 1 small_molecule completed
Quick answer
LB-100 for Injection for Tumors is a Phase 1 program (small_molecule) at LIXTE BIOTECHNOLOGY HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- Indication
- Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed